Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riotto

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Physical Review Letters|February 12, 2021
NANOGrav Data Hints at Primordial Black Holes as Dark MatterV De Luca, G Franciolini, A Riotto
Physical Review Letters|June 7, 2026
GW231123: A Possible Primordial Black Hole OriginValerio De Luca, Gabriele Franciolini, Antonio Riotto
Annales De L'Institut Pasteur|November 1, 1972
[Initiation and inhibition of immunohemolysis by anti-immunoglobulin antibodies]M M Riotto, J Pillot, A E Bussard
Physical Review Letters|November 18, 2022
Ruling Out Initially Clustered Primordial Black Holes as Dark MatterValerio De Luca, Gabriele Franciolini, Antonio Riotto, et al.
Physical Review Letters|September 26, 2012
Asymmetric Higgsino dark matterKfir Blum, Aielet Efrati, Yuval Grossman, et al.
Eye (London, England)|February 23, 2026
Infographic: ranibizumab for neovascular age-related macular degeneration: the MARINA studyFrancesca Lamanna, Eleonora Riotto, Livia Faes, et al.
Physical Review Letters|September 6, 2024
Black Hole Formation-Null Geodesic CorrespondenceAndrea Ianniccari, Antonio J Iovino, Alex Kehagias, et al.
Plos One|June 4, 2025
Associations between death anxiety and fear of illness progression or recurrence: A protocol for a systematic review and meta-analysisTadgh Connery, Grazia D Riotto, Daniel Macdonald, et al.
Journal of Psychosomatic Research|September 20, 2025
The relationship between death anxiety and fear of recurrence and progression in chronic illness: A systematic review and meta-analysisRachel E Menzies, Tadgh Connery, Daniel Macdonald, et al.
Eye (London, England)|February 16, 2026
Infographic: five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (DRCR Protocol T Extension Study)Eleonora Riotto, Francesca Lamanna, Venughanan Manikavasagar, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Physical Review Letters|February 12, 2021
NANOGrav Data Hints at Primordial Black Holes as Dark MatterV De Luca, G Franciolini, A Riotto
Physical Review Letters|June 7, 2026
GW231123: A Possible Primordial Black Hole OriginValerio De Luca, Gabriele Franciolini, Antonio Riotto
Annales De L'Institut Pasteur|November 1, 1972
[Initiation and inhibition of immunohemolysis by anti-immunoglobulin antibodies]M M Riotto, J Pillot, A E Bussard
Physical Review Letters|November 18, 2022
Ruling Out Initially Clustered Primordial Black Holes as Dark MatterValerio De Luca, Gabriele Franciolini, Antonio Riotto, et al.
Physical Review Letters|September 26, 2012
Asymmetric Higgsino dark matterKfir Blum, Aielet Efrati, Yuval Grossman, et al.
Eye (London, England)|February 23, 2026
Infographic: ranibizumab for neovascular age-related macular degeneration: the MARINA studyFrancesca Lamanna, Eleonora Riotto, Livia Faes, et al.
Physical Review Letters|September 6, 2024
Black Hole Formation-Null Geodesic CorrespondenceAndrea Ianniccari, Antonio J Iovino, Alex Kehagias, et al.
Plos One|June 4, 2025
Associations between death anxiety and fear of illness progression or recurrence: A protocol for a systematic review and meta-analysisTadgh Connery, Grazia D Riotto, Daniel Macdonald, et al.
Journal of Psychosomatic Research|September 20, 2025
The relationship between death anxiety and fear of recurrence and progression in chronic illness: A systematic review and meta-analysisRachel E Menzies, Tadgh Connery, Daniel Macdonald, et al.
Eye (London, England)|February 16, 2026
Infographic: five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (DRCR Protocol T Extension Study)Eleonora Riotto, Francesca Lamanna, Venughanan Manikavasagar, et al.
Pageof 5